Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.
In Beijing, he finally felt at home. Over the next few years, his strong social connections helped him discover and build a ...
The nation will scrutinize every EV rebate earmarked for Tesla and won't allow it into future programs as long as tariffs ...
Long-threatened tariffs from U.S. President Donald Trump have plunged the country into a global trade war — all while ...
Cardenas, whose company and its Apollo robot has backing from tech giants Nvidia and Google, said a national strategy in the ...
When Xi came to power in 2012, his love for the sport spurred a drive to reform and improve Chinese football. His dream, he ...
Rosenberg stressed the danger posed by the Chinese Communist Party. He cited official U.S. sources to back his concerns.
Others are more precise with their definitions. Some say that “high speed” starts at 125 mph. But others say those trains are ...
American narratives on China in U.S. foreign policy have evolved over centuries, shaped by enduring discourses rooted in ...
Lawson's two Grand Prix with Red Bull were nothing short of a disaster. The 23-year-old failed to make it out of Q1 in both ...
Greenland’s minerals draw U.S. interest, but Arctic conditions, local opposition, and supply chain gaps limit near-term strategic gains.